| 5.04 0.04 (0.8%) | 09-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.12  |
1-year : | 6.52 |
| Resists | First : | 5.24 |
Second : | 5.59 |
| Pivot price | 5.07  |
|||
| Supports | First : | 4.69 | Second : | 3.9 |
| MAs | MA(5) : | 5.17 |
MA(20) : | 5.05 |
| MA(100) : | 5.54 |
MA(250) : | 6.72 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 41.3 |
D(3) : | 54.5 |
| RSI | RSI(14): 46.6 |
|||
| 52-week | High : | 16.59 | Low : | 4.69 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NEUE ] has closed above bottom band by 44.7%. Bollinger Bands are 32% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.21 - 5.24 | 5.24 - 5.27 |
| Low: | 4.94 - 4.97 | 4.97 - 5.01 |
| Close: | 4.98 - 5.04 | 5.04 - 5.09 |
NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.
Mon, 24 Jun 2024
NeueHealth Secures up to $150 Million in New Term Loan Facility with Hercules Capital - Business Wire
Tue, 18 Jun 2024
NeueHealth Receives NYSE Non-Compliance Letter Regarding Market Capitalization Requirements - StockTitan
Sat, 11 May 2024
NeueHealth, Inc. (NYSE:NEUE) Q1 2024 Earnings Call Transcript - Yahoo Finance
Wed, 08 May 2024
NeueHealth posts $242M in revenue, turns small adjusted EBITDA profit - Fierce healthcare
Tue, 09 Apr 2024
NeueHealth Enters into Amendment to its Credit Facility - Business Wire
Wed, 06 Mar 2024
NeueHealth Reports Fourth Quarter and Full Year 2023 Results - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 8 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 5.9 (%) |
| Held by Institutions | 63.1 (%) |
| Shares Short | 25 (K) |
| Shares Short P.Month | 20 (K) |
| EPS | -61.91 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -158.45 |
| Profit Margin | -90.8 % |
| Operating Margin | -11.5 % |
| Return on Assets (ttm) | -3.6 % |
| Return on Equity (ttm) | -257.8 % |
| Qtrly Rev. Growth | -24.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 124.39 |
| EBITDA (p.s.) | -15.52 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2,080 (M) |
| Levered Free Cash Flow | 788 (M) |
| PE Ratio | -0.09 |
| PEG Ratio | -0.1 |
| Price to Book value | -0.04 |
| Price to Sales | 0.04 |
| Price to Cash Flow | -0.03 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|